Biomarkers are measurable indicators that can be used to predict how well a patient will respond to a particular treatment. Common biomarkers in cancer include EGFR mutations, HER2 overexpression, and PD-L1 levels. These biomarkers can help guide treatment decisions and improve outcomes.
